Epilepsy is not caused by cysticercosis in The Gambia

Tropical Medicine and International Health

Volumn 15, Issue 4, 2010, Pages 476-479

  Secka, A ^a   Grimm, F ^b   Victor, B ^c   Marcotty, T ^c   De Deken, R ^c   Nyan, O ^d   Herera, O ^d   Van Marck, E ^e   Geerts, S ^c  

^a International Trypanotolerance Centre Gambia   (Gambia)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^d Royal Victoria Teaching Hospital Gambia   (Gambia)

^e UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Antigen ELISA; Case control study; Computed tomography; Electro immunotransfer blot; Epilepsy; Neurocysticercosis; The Gambia

Indexed keywords

PARASITE ANTIGEN;

AGE CLASS; ANTIGEN; COHORT ANALYSIS; IMMUNOASSAY; NEUROLOGY; PARASITIC DISEASE; SAMPLING; SPATIOTEMPORAL ANALYSIS;

ADOLESCENT; ADULT; AGED; ANTIGEN ANTIBODY COMPLEX; ANTIGEN DETECTION; ARTICLE; BRAIN CYST; CASE CONTROL STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CYSTICERCUS (CESTODE LARVA); DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; ELECTROIMMUNOASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPILEPSY; FEMALE; GAMBIA; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROCYSTICERCOSIS; TAENIA SOLIUM;

ADULT; AGED; ANIMALS; ANTIGENS, HELMINTH; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPILEPSY; FEMALE; GAMBIA; HUMANS; IMMUNOBLOTTING; MALE; MIDDLE AGED; NEUROCYSTICERCOSIS; QUESTIONNAIRES; TAENIA SOLIUM; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

GAMBIA;

TAENIA; TAENIA SOLIUM;

EID: 77949381090     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2010.02470.x     Document Type: Article

References (19)

1. Brandt JRA, Geerts S, De Deken R et al. (1992) A monoclonal antibody-based ELISA for detection of circulating excretory-secretory antigens in Taenia saginata cysticercosis. International Journal of Parasitology 4, 471-477.
2. Carabin H, Krecek RC, Cowman LD et al. (2006) Estimation of the cost of Taenia solium cysticercosis in Eastern Cape Province, South Africa. Tropical Medicine and International Health 11, 906-916.
3. Carpio A & Hauser WA (2002) Prognosis for seizures recurrence in patients with newly diagnosed neurocysticercosis. Neurology 10, 1730-1734.
4. Erhart A, Dorny P, De NV et al. (2002) Taenia solium cysticercosis in village in northern Viet Nam: seroprevalence study using an ELISA for detecting circulating antigen. Transactions of the Royal Society of Tropical Medicine and Hygiene 96, 270-272.
5. Garcia HH, Parkhouse RM, Gilman RH et al. (2000) Serum antigen detection in the diagnosis, treatment, and follow-up of neurocysticercosis patients. Transactions of the Royal Society of Tropical Medicine and Hygiene 94, 673-676.
6. Garcia HH, Gonzalez AE, Evans CAW, Gilman RH & Cysticercosis Working Group in Peru (2003) Taenia solium cysticercosis. Lancet 362, 547-556.
7. Houinato D, Ramanankandrasana B, Adjide C et al. (1998) Seroprevalence of cysticercosis in Bénin. Transactions of the Royal Society of Tropical Medicine and Hygiene 92, 621-624.
8. ILAE (1989) Commission on classification and terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 30, 389-399.
9. Nash TE, Garcia HH, Rajshekhar V et al. (2005) Clinical cysticercosis: diagnosis and treatment. In: WHO?FAO?OIE Guidelines for the surveillance, prevention and control of taeniosis?cysticercosis (ed. D Murrell). Paris, pp. 11-26.
10. Nguekam, Zoli AP, Ongolo-Zogo P et al. (2003) Follow-up of neurocysticercosis patients after treatment using an antigen detection ELISA. Parasite 10, 65-68.
11. Norlinah I, Raymond AA, Hamildon B & Pramod P (2003) Neurocysticercosis in a Malaysian Muslim. Neurol Journal of South-East Asia 8, 45-48.
12. Nsengiyumva G, Druet-Cabanac M, Ramanankandrasana B et al. (2003) Cysticercosis as a Major Risk Factor For Epilepsy in Burundi, East Africa. Epilepsia 44, 950-955.
13. Prado-Jean A, Kanobana K, Druet-Cabanac M et al. (2007) Combined use of an antigen and antibody detection enzyme-linked immunosorbent assay for cysticercosis as tools in an epidemiological study of epilepsy in Burundi. Tropical Medicine and International Health 12, 895-901.
14. Preux PM & Druet-Cabanac M (2005) Epidemiology and aetiology of epilepsy in sub-Saharan Africa. Lancet Neurology 4, 21-31.
15. Rodriguez S, Dorny P, Victor CW et al. (2009) Detection of Taenia solium Antigens and Anti-T. solium Antibodies in Paired Serum and Cerebrospinal Fluid Samples from Patients with Intraparenchymal or Extraparenchymal Neurocysticercosis. Journal of Infectious Diseases 199, 1345-1352.
16. Sokal RR & Rohlf FJ (1981) Biometry, 2nd edn. Freeman & Co., New York, pp. 229-331.
17. Tsang VC, Brand JA & Boyer AE (1989) An enzyme-linked immunoelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium). Journal of Infectious Diseases 159, 50-59.
18. Vondou L, Zoli AP, Nguekam et al. (2002) La taeniose?cysticercose à Taenia solium dans la Menoua (Ouest-Cameroun). Parasite 9, 271-274.
19. Wilson M, Bryan RT, Fried JA et al. (1991) Clinical evaluation of the cysticercosis enzyme- linked immunoelectrotransfer blot in patients with neurocysticercosis. Journal of Infectious Diseases 164, 1007-1009.